MACULAR EDEMA SECONDARY TO INFLAMMATION
Clinical trials for MACULAR EDEMA SECONDARY TO INFLAMMATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR EDEMA SECONDARY TO INFLAMMATION trials appear
Sign up with your email to follow new studies for MACULAR EDEMA SECONDARY TO INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye drug aims to restore sight in patients with inflammatory swelling
Disease control Recruiting nowThis study tests an investigational eye injection called KSI-101 for people with macular edema (swelling in the central part of the retina) caused by inflammation. About 150 participants will receive either the drug or a sham injection to see if it improves vision over 24 weeks. …
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated May 17, 2026 20:20 UTC
-
New eye drug aims to restore vision in inflammatory swelling
Disease control Recruiting nowThis study tests an experimental eye injection called tabirafusp alfa (KSI-101) for people with macular edema (swelling in the back of the eye) caused by inflammation. About 150 adults with active or past eye inflammation and mild to moderate vision loss will receive either the d…
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated May 17, 2026 20:05 UTC